Stephen J. Oliver

Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

Thomas Dörner, Maximilian Posch, Yue Li et al. · Annals of the Rheumatic Diseases · 2019 · 200 citations

Life Sciences, Immunology, Pharmacology +17

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans

Deepak Cyril D’Souza, Gabriel Braley, Rebecca Blaise et al. · Psychopharmacology · 2008 · 122 citations · Full text

Medicine, Neuroscience, Pharmacology +11

CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism

Sabine Ring, Stephen J. Oliver, Bruce N. Cronstein et al. · Journal of Allergy and Clinical Immunology · 2009 · 107 citations

Life Sciences, Immunology, Molecular Biology +12

Suppression of Collagen-Induced Arthritis Using an Angiogenesis Inhibitor, AGM-1470, and a Microtubule Stabilizer, Taxol

Stephen J. Oliver, Mona Lisa Banquerigo, Ernest Brahn · Cellular Immunology · 1994 · 101 citations

Medicine, Oncology, Pharmacology +12

Suppression of Collagen-Induced Arthritis by an Angiogenesis Inhibitor, AGM-1470, in Combination with Cyclosporin: Reduction of Vascular Endothelial Growth Factor (VEGF)

Stephen J. Oliver, Tammy P. Cheng, Mona Lisa Banquerigo et al. · Cellular Immunology · 1995 · 94 citations

Medicine, Immunology, Pharmacotherapy +16